Literature DB >> 16551246

The eosinophil.

Marc E Rothenberg1, Simon P Hogan.   

Abstract

Eosinophils have been considered end-stage cells involved in host protection against parasites. However, numerous lines of evidence have now changed this perspective by showing that eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of diverse inflammatory responses, as well as modulators of innate and adaptive immunity. In this review, we summarize the biology of eosinophils, focusing on the growing properties of eosinophil-derived products, including the constituents of their granules as well as the mechanisms by which they release their pleiotropic mediators. We examine new views on the role of eosinophils in homeostatic function, including developmental biology and innate and adaptive immunity (as well as interaction with mast cells and T cells). The molecular steps involved in eosinophil development and trafficking are described, with special attention to the important role of the transcription factor GATA-1, the eosinophil-selective cytokine IL-5, and the eotaxin subfamily of chemokines. We also review the role of eosinophils in disease processes, including infections, asthma, and gastrointestinal disorders, and new data concerning genetically engineered eosinophil-deficient mice. Finally, strategies for targeted therapeutic intervention in eosinophil-mediated mucosal diseases are conceptualized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551246     DOI: 10.1146/annurev.immunol.24.021605.090720

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  519 in total

Review 1.  Approach to patients with eosinophilia.

Authors:  Lanny J Rosenwasser
Journal:  Mo Med       Date:  2011 Sep-Oct

Review 2.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

Review 3.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Authors:  Jennifer Kearley; Karen F Buckland; Sara A Mathie; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

5.  Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation.

Authors:  Amy L Radke; Lauren E Reynolds; Rossana C N Melo; Ann M Dvorak; Peter F Weller; Lisa A Spencer
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 6.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

7.  Temporal changes in myeloid cells in the cervix during pregnancy and parturition.

Authors:  Brenda C Timmons; Anna-Marie Fairhurst; Mala S Mahendroo
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry.

Authors:  Whitney W Stevens; Taeg S Kim; Lindsey M Pujanauski; Xueli Hao; Thomas J Braciale
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

9.  MiR-223 deficiency increases eosinophil progenitor proliferation.

Authors:  Thomas X Lu; Eun-Jin Lim; John A Besse; Svetlana Itskovich; Andrew J Plassard; Patricia C Fulkerson; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

10.  Differentiating asthma phenotypes in young adults through polyclonal cytokine profiles.

Authors:  Edward Zoratti; Suzanne Havstad; Ganesa Wegienka; Charlotte Nicholas; Kevin R Bobbitt; Kimberley J Woodcroft; Dennis R Ownby; Christine Cole Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-05       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.